Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Henry Fuchs Insider Profile
4 Followers
Henry Fuchs, President, Worldwide R&D at BioMarin Pharmaceutical, holds 185.07K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 10.46K shares in Mirati Therapeutics (Ticker: MRTX), holds 0.00 shares in Genomic Health (Ticker: GHDX).
Henry Fuchs BioMarin Pharmaceutical (BMRN)President, Worldwide R&D
BioMarin Pharmaceutical (BMRN)
President, Worldwide R&D
Ranked #94,031 out of 99,335 Corporate Insiders
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
-43.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
President, Worldwide R&D
Roles that Henry Fuchs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 28, 2018 - Aug 28, 2019
Return:+25.50%
The most profitable trade made by Henry Fuchs
Henry Fuchs's Trading History
BioMarin Pharmaceutical
Sep 17, 2024
President, Worldwide R&D
Uninformative Buy
20.59K
$11.89M
Genomic Health
Nov 14, 2019
―
Uninformative Sell
―
$0.00
Mirati Therapeutics
Jan 24, 2023
―
Uninformative Buy
―
$614.30K
Onyx Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Henry Fuchs's performance on stock
You May Also Like
Henry Fuchs insider profile FAQ
What is the percentage of profitable transactions made by Henry Fuchs?
The percentage of profitable transactions made by Henry Fuchs is 44%.
What is the average return per transaction made by Henry Fuchs?
The average return per transaction made by Henry Fuchs is -43.60%.
What stocks does Henry Fuchs hold?
Henry Fuchs holds: BMRN, GHDX, MRTX, ONXX stocks.
What was Henry Fuchs’s latest transaction?
Henry Fuchs latest transaction was an Uninformative Buy of $20.59K.
What was Henry Fuchs's most profitable transaction?
Henry Fuchs’s most profitable transaction was an Informative Sell of BMRN stock on August 28, 2018. The return on the trade was 25.50%.
What is Henry Fuchs's role in BioMarin Pharmaceutical?
Henry Fuchs's role in BioMarin Pharmaceutical is President, Worldwide R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.